Parallel distribution in pharmaceuticals creates competition in a business where patents provide the rights owner with a monopoly. This is good for the European economy, good for health care systems and good for patients. The European Association of Euro-Pharmaceutical Companies (EAEPC) is the only Brussels-based non-profit organisation which brings together the licensed European pharmaceutical parallel distribution industry, championing the industry's achievements and the benefits of its products.

Parallel distributors are registered as pharmaceutical wholesalers who supply the intra-European market (often called 'exporters') or who place medicines from another country market in their market of destination (often called 'importers') who must in addition hold a manufacturing authorisation for the necessary repackaging.

Through the direct membership of 14 national associations and 21 individual companies, the EAEPC encompasses about 100 firms from 23 countries engaged in parallel distribution in the European Economic Area (EEA), representing 80 percent of the volume of the overall industry. EAEPC member companies are nearly all privately owned small- to medium-sized enterprises (SMEs).

All products handled by EAEPC members have national and/or EU regulatory approval and are exclusively sourced from and sold to European Economic Area (EEA) countries using only authorised trade channels.

The primary goal of the EAEPC is to enable, safeguard and foster parallel distribution in branded medicinal products. The association is committed to free trade within the EEA, competition in the European Single Market and to the completion of a functioning EU internal market.

To achieve its goals and support its members’ business, the EAEPC undertakes the following actions:

  1. Analysing activities and initiatives in the area of pharmaceutical parallel distribution
  2. Providing members with relevant data and information to inform their decision making
  3. Offering a platform for members to network, gather knowledge and share expertise
  4. Carrying out scientific studies and analyses of our member’s activities to bring the industry together under specific commitments and joint actions to improve their competitiveness
  5. Encouraging members to promote and co-operate in the development of parallel distribution as a means of completing the EU single market and providing innovative medicines to all Europeans at affordable prices
  6. Co-operating with other associations that have similar or interrelated interests
  7. Ensuring the acceptance of the Added Value provided by parallel distribution
  8. Promoting the application of the EAEPC Guidelines on Good Parallel Distribution Practices (Code of Operational Conduct) by its Members and other operators within the parallel distribution industry
  9. Monitoring relevant policy initiatives at EU and international level, contributing with technical information, representing the industry vis-à-vis third parties and assisting in implementing legislation.

The EAEPC stands for the visibility of the industry and acts on emerging issues, making the EAEPC a valuable source of expertise and constructive counterpart for government institutions and health care payers at the European and national level.

The EAEPC was founded in June 1998 but parallel distribution in medicines began long before the association, more than four decades ago. The original pioneers imported products from Italy into Germany and the UK. Soon after, medicines were increasingly traded from Greece and Spain into Scandinavia.

For a while parallel distribution operated mostly from the South to the North but in the last fifteen years, enabled by the European Single Market, parallel distribution has become a veritable intra-European activity. Nearly all EEA countries, where no barriers to trade exist, experience and benefit from incoming and outgoing parallel distribution.

The EAEPC is and remains the only body to bring together pharmaceutical parallel distributors from across the European Economic Area (EEA).

The EAEPC operates through 4 Working Groups that address the variety of issues facing the parallel distribution industry (legal, regulatory, advocacy and FMD).

The Working Groups report to the Secretariat which coordinates and manages the day-to-day work of the EAEPC. The Secretariat is based in Brussels.

The Secretariat is overseen by the Board which sets the EAEPC’s strategic objectives and approves EAEPC policy positions as well as ensures good and transparent governance. Major decisions, e.g. on the annual budget, election of directors, approval of new members are the domain of the twice-yearly General Assembly.

EAEPC is listed in the EU’s Transparency Register. Registration nr.: 509882515669-01

EAEPC Secretariat

Kasper Ernest

Secretary-General

Read More ...

Richard Freudenberg

President - Chief Executive

Read More ...

Heinz Kobelt

Director European Affairs

Read More ...

Oliver Luksic

Chief Adviser Trade and Competition 

Read More ...

Claudie Tallineau

Office Manager

Read More ...

Rue des Deux Eglises 26 
B-1000 Brussels (Belgium)

Tel: +32 491 25 56 11‬

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.